Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?

K. Subramaniam; K. Tucker; P. Craft; P. Pavli

doi:10.1002/ibd.21883

Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?

K. Subramaniam^*, K. Tucker, P. Craft, P. Pavli

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Abstract

N/A - Editorial

Original language	English
Pages (from-to)	E151-E152
Journal	Inflammatory Bowel Diseases
Volume	17
Issue number	11
DOIs	https://doi.org/10.1002/ibd.21883
Publication status	Published - Nov 2011
Externally published	Yes

Access to Document

10.1002/ibd.21883

Cite this

@article{2040bf86d9364a37b6faca48f3d666d1,

title = "Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?",

abstract = "N/A - Editorial",

author = "K. Subramaniam and K. Tucker and P. Craft and P. Pavli",

year = "2011",

month = nov,

doi = "10.1002/ibd.21883",

language = "English",

volume = "17",

pages = "E151--E152",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",